Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 42 | $2,505,933 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 31 Mar 2025 19:37 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Mar 2025 | Sale | 3,250 | 21.3295 | 69,321 | D |
| 26 Mar 2025 19:37 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 24 Mar 2025 | Sale | 1,000 | 22.5045 | 22,504 | D |
| 03 Mar 2025 20:07 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Feb 2025 | Sale | 3,250 | 20.4083 | 66,327 | D |
| 07 Feb 2025 19:06 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 05 Feb 2025 | Sale | 1,000 | 22.5244 | 22,524 | D |
| 29 Jan 2025 19:21 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Jan 2025 | Sale | 3,250 | 21.5932 | 70,178 | D |
| 07 Jan 2025 16:43 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 03 Jan 2025 | Sale | 1,000 | 25.0386 | 25,039 | D |
| 31 Dec 2024 17:18 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Dec 2024 | Sale | 3,350 | 22.1549 | 74,219 | D |
| 31 Dec 2024 17:18 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 30 Dec 2024 | Sale | 900 | 22.5061 | 20,255 | D |
| 02 Dec 2024 17:18 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Nov 2024 | Sale | 4,250 | 24.7795 | 105,313 | D |
| 02 Dec 2024 17:18 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Nov 2024 | Sale | 1,000 | 25.3755 | 25,376 | D |
| 30 Oct 2024 18:04 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 28 Oct 2024 | Sale | 5,600 | 28.4933 | 159,562 | D |
| 30 Oct 2024 18:04 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 28 Oct 2024 | Sale | 650 | 29.111 | 18,922 | D |
| 22 Oct 2024 16:19 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 18 Oct 2024 | Sale | 814 | 30.003 | 24,422 | D |
| 08 Oct 2024 18:56 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 04 Oct 2024 | Sale | 10,218 | 27.5082 | 281,079 | D |
| 08 Oct 2024 18:56 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 07 Oct 2024 | Sale | 1,270 | 27.5081 | 34,935 | D |
| 03 Oct 2024 18:44 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 01 Oct 2024 | Sale | 521 | 27.5372 | 14,347 | D |
| 01 Oct 2024 19:53 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Sep 2024 | Sale | 4,250 | 24.2732 | 103,161 | D |
| 01 Oct 2024 19:53 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 30 Sep 2024 | Sale | 2,000 | 25.3338 | 50,668 | D |
| 29 Aug 2024 18:36 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Aug 2024 | Sale | 4,250 | 22.5369 | 95,782 | D |
| 02 Aug 2024 19:23 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 31 Jul 2024 | Sale | 991 | 27.5287 | 27,281 | D |
| 31 Jul 2024 19:31 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 29 Jul 2024 | Sale | 61 | 27.4431 | 1,674 | D |
| 31 Jul 2024 19:31 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 29 Jul 2024 | Sale | 5,189 | 26.6676 | 138,378 | D |
| 16 Jul 2024 17:34 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 12 Jul 2024 | Sale | 3,000 | 25.065 | 75,195 | D |
| 01 Jul 2024 20:03 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Jun 2024 | Sale | 1,140 | 23.4308 | 26,711 | D |
| 01 Jul 2024 20:03 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Jun 2024 | Sale | 1,830 | 22.5756 | 41,313 | D |
| 01 Jul 2024 20:03 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Jun 2024 | Sale | 1,280 | 21.7946 | 27,897 | D |
| 30 May 2024 17:54 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 28 May 2024 | Sale | 10 | 24.34 | 243 | D |
| 30 May 2024 17:54 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 28 May 2024 | Sale | 2,334 | 23.4184 | 54,659 | D |
| 30 May 2024 17:54 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 28 May 2024 | Sale | 1,906 | 22.89 | 43,628 | D |
| 07 May 2024 18:58 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 03 May 2024 | Sale | 1,000 | 22.5 | 22,500 | D |
| 01 May 2024 19:02 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 29 Apr 2024 | Sale | 3,250 | 16.9737 | 55,165 | D |
| 15 Apr 2024 19:04 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 11 Apr 2024 | Sale | 10,223 | 25.0386 | 255,970 | D |
| 15 Apr 2024 19:04 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 11 Apr 2024 | Sale | 3,777 | 23.8759 | 90,179 | D |
| 29 Mar 2024 17:59 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Mar 2024 | Sale | 182 | 18.7186 | 3,407 | D |
| 29 Mar 2024 17:59 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Mar 2024 | Sale | 3,068 | 18.2189 | 55,896 | D |
| 29 Feb 2024 17:27 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 27 Feb 2024 | Sale | 3,250 | 16.9732 | 55,163 | D |
| 31 Jan 2024 21:20 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | CHIEF FINANCIAL OFFICER | 29 Jan 2024 | Sale | 3,250 | 15.8118 | 51,388 | D |
| 02 Jan 2024 19:59 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | Chief Financial Officer | 02 Jan 2024 | Sale | 9,383 | 15.01 | 140,839 | D |
| 02 Jan 2024 19:59 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | Chief Financial Officer | 29 Dec 2023 | Sale | 20 | 15 | 300 | D |
| 02 Jan 2024 19:59 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | Chief Financial Officer | 28 Dec 2023 | Sale | 2,467 | 15.0742 | 37,188 | D |
| 27 Dec 2023 17:26 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | Chief Financial Officer | 22 Dec 2023 | Sale | 1,030 | 15.0728 | 15,525 | D |
| 27 Dec 2023 17:26 | ELVN | Enliven Therapeutics Inc | HOHL BENJAMIN | Chief Financial Officer | 26 Dec 2023 | Sale | 100 | 15 | 1,500 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)